Rayovac invests an extra £1m in the North East
HEARING aid battery manufacturer Rayovac has invested an extra £1m in the North East as it steps up production of its new, mercury-free range.
Novartis, the Swiss pharmaceuticals group, plans to invest $500m in Russia in the coming five years in a move to bolster its position in the market and bypass tougher regulations on imported medicines.